Compare ASG & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASG | GEVO |
|---|---|---|
| Founded | 1986 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.1M | 470.1M |
| IPO Year | N/A | 2011 |
| Metric | ASG | GEVO |
|---|---|---|
| Price | $5.30 | $2.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.13 |
| AVG Volume (30 Days) | 324.3K | ★ 3.0M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | ★ 8.09% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,932,000.00 |
| Revenue This Year | N/A | $927.85 |
| Revenue Next Year | N/A | $12.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 675.75 |
| 52 Week Low | $4.47 | $0.92 |
| 52 Week High | $5.71 | $2.98 |
| Indicator | ASG | GEVO |
|---|---|---|
| Relative Strength Index (RSI) | 44.81 | 60.50 |
| Support Level | $5.29 | $2.16 |
| Resistance Level | $5.39 | $2.42 |
| Average True Range (ATR) | 0.06 | 0.12 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 62.06 | 86.92 |
Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.